We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
-3.92%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.18B
AUM Growth
-$14.4M
Cap. Flow
+$35M
Cap. Flow %
2.96%
Top 10 Hldgs %
62.21%
Holding
83
New
12
Increased
32
Reduced
19
Closed
14

Top Buys

Rank Stock Value
1
INSP icon
Inspire Medical Systems
INSP
+$27.9M
2
HQY icon
HealthEquity
HQY
+$22.9M
3
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$15.2M
4
GSK icon
GSK
GSK
+$13.4M
5
TSVT
2seventy bio
TSVT
+$9.53M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29M
2
CTLT
CATALENT, INC.
CTLT
+$15.5M
3
ICLR icon
Icon
ICLR
+$12.8M
4
ABCM
Abcam PLC
ABCM
+$12.2M
5
AMRX icon
Amneal Pharmaceuticals
AMRX
+$9.77M

Sector Composition

Rank Sector Weight
1 Healthcare 76.1%
2 Miscellaneous 23.9%
3 Communication Services 0%
4 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOSS icon
51
Gossamer Bio
GOSS
$83.2M
$3.69M 0.31%
4,427,857
+3,678,160
+491% +$4.24M
RVTY icon
52
Revvity
RVTY
$14.4B
$3.62M 0.31%
32,698
+11,384
+53% +$1.34M
CVAC
53
DELISTED
CureVac
CVAC
$3.53M 0.3%
516,794
+159,452
+45% +$1.41M
BHVN icon
54
Biohaven
BHVN
$2.33B
$3.41M 0.29%
131,103
– –
PODD icon
55
Insulet
PODD
$10.1B
$3.4M 0.29%
+21,299
New +$4.77M
MRUS
56
DELISTED
Merus
MRUS
$3.16M 0.27%
134,010
+2,784
+2% +$67.5K
STRO icon
57
Sutro Biopharma
STRO
$339M
$2.67M 0.23%
76,964
+2,173
+3% +$94.7K
RGEN icon
58
Repligen
RGEN
$9.95B
$2.57M 0.22%
16,153
-49,914
-76% -$8.16M
ARGX icon
59
argenx
ARGX
$64B
$2.24M 0.19%
4,565
+411
+10% +$201K
MEDP icon
60
Medpace
MEDP
$16.8B
$2.14M 0.18%
8,823
-6,741
-43% -$1.72M
AVTR icon
61
Avantor
AVTR
$9.86B
$1.78M 0.15%
+84,495
New +$1.8M
BBIO icon
62
PUT
BridgeBio Pharma
BBIO
$15B
$1.47M 0.12%
+55,800
New +$1.58M
XBI icon
63
State Street SPDR S&P Biotech ETF
XBI
$11.3B
$1.46M 0.12%
+20,000
New +$1.6M
XOMA
64
DELISTED
Xoma
XOMA
$1.27M 0.11%
89,950
– –
BDTX icon
65
Black Diamond Therapeutics
BDTX
$128M
$968K 0.08%
337,131
-90,186
-21% -$332K
AFMD
66
DELISTED
Affimed
AFMD
$801K 0.07%
167,668
– –
JBIO
67
Jade Biosciences
JBIO
$1.33B
$682K 0.06%
1,435
– –
WHWK
68
Whitehawk Therapeutics
WHWK
$263M
$493K 0.04%
101,918
– –
ACIU icon
69
AC Immune
ACIU
$263M
$355K 0.03%
124,589
– –
EHTH icon
70
eHealth
EHTH
$38.4M
– –
-503,079
Closed -$4.04M
EOLS icon
71
Evolus
EOLS
$587M
– –
-228,679
Closed -$1.66M
KYNB
72
Kyntra Bio
KYNB
$32.5M
– –
-224
Closed -$15.1K
KYNB
73
PUT
Kyntra Bio
KYNB
$32.5M
– –
-1,552
Closed -$105K
GOCO
74
DELISTED
GoHealth
GOCO
– –
-104,820
Closed -$2.07M
KURA icon
75
Kura Oncology
KURA
$1.13B
– –
-450,622
Closed -$4.77M
1 2
3
4

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q3 2023 Portfolio in Review

As of Q3 2023, Eversept Partners held 83 positions worth $1.18B, down 1.2% from $1.2B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Eversept Partners's Q3 2023 filing shows 12 new, 32 increased, 19 reduced and 14 closed positions. Its largest new stake was HealthEquity: 338,516 shares worth $24.7M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $29M.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 78% a quarter earlier, followed by Miscellaneous and Communication Services.

  • Eversept Partners's largest Q3 2023 buy was HealthEquity: 338,516 shares worth $24.7M.
  • Eversept Partners added most to Inspire Medical Systems in Q3 2023, an estimated $27.9M increase.
  • Eversept Partners's biggest Q3 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $29M.
  • Eversept Partners fully exited CATALENT, INC. in Q3 2023, selling an estimated $15.5M.
  • Eversept Partners's ten largest holdings make up 62% of its $1.18B portfolio in Q3 2023.
  • Eversept Partners opened 12 new positions and closed 14 in Q3 2023.
  • Eversept Partners's portfolio value fell 1.2% quarter-over-quarter to $1.18B.

Based on Eversept Partners's 13F filing for Q3 2023, filed 14 Nov 2023.